INCREASE OLE: Long-term INCREASE data manuscript
Long-term Inhaled Treprostinil for Pulmonary Hypertension due to Interstitial Lung Disease
Waxman A et al. ERJ 2023.
Publications
This content is being provided in response to your request for information. No further reproduction or distribution is permitted.
Some information contained in this content may be outside of the approved Prescribing Information. This information is not intended to endorse or offer recommendations for administration of this product in a manner inconsistent with the Prescribing Information.
For full prescribing information, including indications, contraindications, warnings, precautions, and adverse events, please refer to the FDA-approved product labeling.
INCREASE win ratio manuscript
A novel approach to clinical change endpoints: a win ratio analysis of the INCREASE trial
Nathan S et al. Annals ATS 2023.
INCREASE plain language summary manuscript
Plain language summary of the INCREASE study: inhaled treprostinil (Tyvaso) for the treatment of pulmonary hypertension due to interstitial lung disease
West N et al. Future Cardiology 2023.
PH-ILD screening strategies manuscript
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study
Rahaghi F et al. CHEST 2022.
INCREASE dose response manuscript
Inhaled Treprostinil Dose in Pulmonary Hypertension Associated with Interstitial Lung Disease and Its Effects on Clinical Outcomes
Nathan S et al. CHEST 2022.
INCREASE efficacy after disease progression events manuscript
Efficacy of inhaled treprostinil on multiple disease progression events in patients with pulmonary hypertension due to parenchymal lung disease in the INCREASE trial
Nathan S et al. AJRCCM 2021.
INCREASE FVC improvements manuscript
Inhaled Treprostinil and FVC Change in Patients with Interstitial Lung Disease and Associated Pulmonary Hypertension
Nathan S et al. Lancet Resp Med 2021.
INCREASE primary manuscript
Inhaled Treprostinil in Pulmonary Hypertension due to Interstitial Lung Disease
Waxman A et al. NEJM 2021.
INCREASE supplemental oxygen abstract and poster
The Safety and Efficacy of Inhaled Treprostinil in Patients with PH-ILD on supplemental oxygen: a post-hoc analysis of the INCREASE Study
Sahay S et al. Poster presented at: ATS 2023.
Have a question?
Medical Affairs professionals are available to help with questions regarding UT products.
Call us at: 1-877-522-2950
Email us at: medicalinformation@unither.com